Product Information
ALPRAZOLAM 0.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0225 per EA under NDC 65862067705. Its NADAC has been published 337 times since Apr 22, 2020.
FDA first approved this application on Jul 31, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862067705
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALPRAZOLAMApproval Type
Generic (ANDA)
FDA Application
ANDA203346FDA Approved
7/31/2015
TE Code
AB
On Market Since
7/31/2015
Pharmacological Classes
Price Statistics
The NADAC for ALPRAZOLAM 0.5 MG TABLET has been published 337 times since Apr 22, 2020, and over the history we have for it it has declined 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0225 per EA |
|---|---|
| All-time high | $0.0265 (Aug 16, 2023) |
| All-time low | $0.0187 (Nov 20, 2024) |
| 52-week high | $0.0237 |
| 52-week low | $0.0221 |
| Median price | $0.0231 |
| Average price | $0.0231 |
| Largest weekly change | +29.6% (Jun 19, 2024) |
| Weeks tracked | 337 |
| Tracking since | Apr 22, 2020 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alprazolam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALPRAZOLAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALPRAZOLAM 0.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0225 per EA (NDC 65862067705), effective Sep 30, 2026.
How has the price of ALPRAZOLAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALPRAZOLAM 0.5 MG TABLET has declined 12.2%. It has been tracked across 337 weekly CMS publications since Apr 22, 2020.
What are the highest and lowest recorded NADAC prices for ALPRAZOLAM 0.5 MG TABLET?
Since Apr 22, 2020, the NADAC for ALPRAZOLAM 0.5 MG TABLET has ranged from a low of $0.0187 (Nov 20, 2024) to a high of $0.0265 (Aug 16, 2023), with a median of $0.0231 per EA.
Are there cheaper alternatives to ALPRAZOLAM 0.5 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ALPRAZOLAM 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ALPRAZOLAM 0.5 MG TABLET?
ALPRAZOLAM 0.5 MG TABLET (NDC 65862067705) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.